Timothy Brown, the Berlin patient, marked an unprecedented milestone in 2009 by becoming the first person with HIV to be free of the virus after receiving a very particular stem cell transplant. His emblematic case demonstrated that eradicating the AIDS virus was possible and paved the way for a therapeutic strategy that now includes 10 cases in remission.
I am particularly worried about the immunisation programme. If there is a disruption, the success we have achieved in immunisation will be jeopardised.
The Trump-era patronage system has affected us all, by so often thrusting inexperienced randos with obvious political mandates into important positions that have previously always been occupied by career civil servants or specialized leaders.
On that sunny March morning, in a small health center in Lobamba, a rural area of Eswatini, this 32-year-old sex worker has just become one of the first people in the world to receive lenacapavir, a drug that, administered twice a year, offers nearly 100% protection against HIV.
Kelly Chibale describes the drug discovery process as a fairy-tale quest, stating, 'It doesn't mean that there aren't surprises or miracles. They do happen, but you have to kiss many frogs before you meet the prince.' This metaphor illustrates the challenges and unpredictability in finding effective medicines.
I am open-minded; I believe in integrative practices, and I agree that the medical establishment can be arrogant and unduly influenced by the pharmaceutical industry, which now funds so much of medical research. But I fully understand Scherer's frustration with his interminable discussions with Kennedy about scientific articles.
Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging. At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
Risks of outbreaks with pandemic potential rise with increasing land-use change, biodiversity loss and climate change. The Pandemic Agreement adopted by the World Health Assembly in 2025 marks a historic shift that establishes the One Health approach as a legally binding obligation for pandemic prevention.
At the end of January, Washington, DC, saw an extremely unusual event. The MAHA Institute, which was set up to advocate for some of the most profoundly unscientific ideas of our time, hosted leaders of the best-funded scientific organization on the planet, the National Institutes of Health. Instead of a hostile reception, however, Jay Bhattacharya, the head of the NIH, was greeted as a hero by the audience, receiving a partial standing ovation when he rose to speak.
Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several patients and ran a single test. If the test came back negative, everyone in it was cleared at once. If it was positive, follow-up tests would zero in on who was infected. That strategy, known as group testing, saved valuable time, money, and resources.
The news is the latest sign of the FDA's heightened scrutiny of vaccines under Health Secretary Robert F. Kennedy Jr., particularly those using mRNA technology, which he has criticized before and after becoming the nation's top health official. Moderna received what's called a "refusal-to-file" letter from the FDA that objected to how it conducted a 40,000-person clinical trial comparing its new vaccine to one of the standard flu shots used today.
In his first email to CDC staff, he wrote that the federal government's "decisions, communications, and processes" broke the public's trust during the pandemic, and that "acknowledging this reality is a necessary step toward renewal." In practice, the CDC has been undergoing a kind of forced renewal for months.
The World Health Organization announced in late January that six European countries: the United Kingdom, Spain, Austria, Armenia, Azerbaijan and Uzbekistan had all officially lost their measles elimination status, which means the virus has been circulating continuously in those countries for more than 12 months.
Each day, they pore over reams of data about how the virus is evolving worldwide, how well last year's shot performed, and which strains might be easiest to mass produce for a vaccine. The meeting, convened by the World Health Organization twice a year, is a critical moment for the WHO's Global Influenza Surveillance and Response System.
While the move came as a surprise to the high-profile vaccine maker, it is just the latest hostility toward vaccines-and mRNA vaccines in particular-from an agency overseen by the fervent anti-vaccine activist Robert F. Kennedy Jr. In his first year in office, Kennedy has already dramatically slashed childhood vaccine recommendations and canceled $500 million in research funding for mRNA vaccines against potential pandemic threats.
Has your resilience ever been fractured? Do you yearn to express solidarity in a pragmatic way? Have you signed an MOU? (Or even heard of an MOU?) These sentences contain some of the buzzwords likely to be relevant in the world of global health and development in 2026 according to our informal survey of 20 experts who work in the field.
Half a world away, specialists in Japan say they have some hard-won wisdom to offer. They watched flu and pneumonia deaths spike after the Japanese government stopped pushing parents to have their children vaccinated against influenza. They witnessed rubella outbreaks driven by shifting vaccine guidance that left a segment of the population vulnerable. And they saw an unfounded media scare turn the public away from immunizations against human papillomavirus (HPV), which is responsible for nearly all cases of cervical cancer.
